Comparison Between Propolis and Celecoxib as Anti-inflammatory Agent in Rat with Knee Synovitis by Gunawan, H. (Hendra) & Rasyid, H. N. (Hermawan)
Corresponding author:
Hendra Gunawan, MD
    Jl. Lebak Indah IV No. 15 Lebak Bulus Jakarta 12440
    Phone : 081320261976 
Email : hendrag_md@yahoo.com
10
Perbandingan Efek Anti-inflamasi antara Propolis dan Celecoxib 
terhadap Tikus dengan Sinovitis Lutut
Hendra Gunawan, Hermawan Nagar Rasyid, Nucki Nursjamsi Hidajat, Agus Hadian Rahim
Department of Orthopaedic and Traumatology, Faculty of Medicine Padjadjaran University/ Hasan Sadikin General Hospital, 
Bandung, Indonesia
ABSTRAK
Pendahuluan. Sinovitis merupakan proses awal peradangan sendi, ditandai dengan meningkatnya jumlah mak-
rofag pada sinovium yang berperan penting terhadap kerusakan kartilago dan tulang melalui pembentukan fibroblas. 
Pemberian anti-inflamasi non-steroid (AINS) pada nyeri sendi sering dilakukan, namun efek samping pemberian 
menimbulkan permasalahan tersendiri di bidang kesehatan. Propolis suatu bahan alami banyak dikonsumsi sebagai 
penghilang nyeri sendi lutut, mengandung bioflavonoid dan Caffeic Acid Polyphenol Ester. Beberapa penelitian 
membuktikan efek propolis sebagai anti-inflamasi, namun mekanisme kerjanya dalam menekan jumlah makrofag 
dibandingkan dengan anti inflamasi lain belum pernah diteliti. Dengan demikian, penelitian ini bertujuan memband-
ingkan efek propolis terhadap celecoxib sebagai anti-inflamasi dalam sinovitis lutut tikus. 
Bahan dan cara kerja.  Pada penelitian eksperimental ini digunakan tikus jantan galur Wistar yang dibagi menjadi 
tiga grup. Masing-masing grup diberikan peptidoglikan saja, peptidoglikan dan propolis per oral, serta  peptidoglikan 
dan celecoxib per oral. Skor dari jumlah makrofag dan sinovitis sendi lutut tikus diamati dengan imunohistokimia 
CD-68 dan pewarnaan hematoksilin-eosin pada hari ke-1, ke-3 dan ke-14. Perbedaan skor masing-masing grup dia-
nalisis dengan ANOVA. 
Hasil. Peningkatan jumlah makrofag dan sinovitis untuk semua grup penelitian terjadi pada hari ke-3, selanjutnya 
menurun pada hari ke-14. Terdapat perbedaan bermakna penghambatan jumlah makrofag antara grup 1 dengan 
kedua grup lainnya pada hari ke-3 (p<0.05). Hal tersebut membuktikan bahwa terdapat peran anti-inflamasi. Pada 
hari ke-3 dan ke-14, jumlah makrofag grup 2 lebih sedikit dibandingkan dengan grup 3 dengan perbedaan hingga 5 
kali lipat (p<0.05).  
Kesimpulan. Propolis menghambat jumlah makrofag 4-5 kali lebih kuat dibandingkan dengan celecoxib pada sy-
novitis sendi lutut.
Kata kunci: propolis, celecoxib, makrofag, sinovitis
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Comparison between Propolis and Celecoxib as Anti-inflammatory Agent in Rat with 
Knee Synovitis
ABSTRACT 
Introduction. Synovitis is an inflammation occurs in a joint marked by an increase in macrophage numbers in synovi-
um resulting in cartilago and bone destruction by production of fibroblasts. Administration of non-steroid anti inflam-
mation drug (NSAID) in management of arthritis and synovitis has its own complications, including gastrointestinal 
and bleeding disorder. Propolis, a natural bee product, is recognized as one of traditional pain killers at knee joint pain 
containing flavonoid and caffeic acid phenolic esters (CAPE). Several studies show its anti-inflammation effect, but its 
effect compared to other NSAID is still unknown. Therefore the aim of the study is to compare Propolis and celecoxib 
anti-inflammation effect in rat with knee joint synovitis.
Materials and Methods. In this experimental study, Wistar strain rats were used. They were divided into three groups. 
Each group were given peptidoglycan only, peptidoglycan followed by Propolis, and peptidoglycan followed by cele-
coxib. Scoring based on number of macrophages and synovitis degree were evaluated by immunohistochemistry CD 
68 and HE staining. It was evaluated in day 1, 3, and 14. Those scores were collected and analyzed using ANOVA.
Results. Increasing number of macrophages and synovitis degree for all groups occur on day 3 and continuously de-
creasing until day 14. There is a significant difference in number of macrophages between grup 1 and the other two 
groups on day 3 (p<0.05). It shows that there is an anti-inflammation effect of both propolis and celecoxib. On day 3 
and 14, the number of macrophages in grup 2 were five times  lower than grup 3. (p<0.05)
Conclusions. Propolis anti-inflammation effect shows 4-5 folds stronger than celecoxib in knee joint synovitis. 
Keywords: celecoxib, macrophage, propolis, synovitis
Introduction
Arthritis is a term used to describe more than hundred dif-
ferent joint disorders; meanwhile synovitis is an inflamma-
tory process in synovial membrane that follows arthritis.1 
Synovitis still remains as a worldwide health problem re-
garding complications due to dysfunction of the affected 
joint as result of progressivity and inadequate treatment. 
Annual survey in United States in 2008 stated that there 
are approximately 50 million people diagnosed as arthritis,2 
744,000 people treated, 9,367 die and 19 million people liv-
ing with restricted joint mobility.1 
The principle management of synovitis either conserva-
tive or operative is relieving pain, joint resting and immo-
bilization, debridement and surgical synovectomy, besides 
the causative therapy. Symptomatic therapy to relieve pain 
using non-steroidal anti-inflammatory drugs (NSAID) has 
led to health problems due to their side effects, such as gas-
trointestinal system discomfort and bleeding disorders. The 
long term duration of using NSAID, even with newest class 
of selective inhibitor of cyclooxygenase-2 (COX-2) can 
cause its own complications. 
Some of herbal have been proposed as alternative in 
treatment of joint pain. They provide efficacy and reduce 
NSAID side effect. One of those substances is Propolis 
which is derived from bee hive and its saliva. It has been 
widely consumed as food supplement and is efficacious to 
relieve joint pain empirically.7 Its active compound, caffeic 
acid phenolic esters (CAPE) and flavonoids, has anti-free 
radical and anti-inflammatory effect.7 The dose 100 mg/
kgBW/day of Propolis for 7 days orally has proven inhibit 
swelling, granuloma and exudate in rat leg significantly.10
There have been many scientific publications about the 
role of Propolis as a free radical scavenger and anti-inflam-
matory properties, but its effectiveness in synovitis com-
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pared with NSAIDs have not been investigated. The aim of 
this study is to compare the antiinflammatory effect between 
Propolis and celecoxib in rat with knee joint synovitis. 
Materials and methods
This experimental study was conducted using Propolis from 
the PT MNI®-Melia Nature Indonesia and GMP standard-
ized, Celecoxib from Pfizer®, and Peptidoglycan 1 mg ster-
ile powder from Sigma-Aldrich® 77 140.
Subjects were Wistar strain rat derived from PT Bio-
farma. Inclusion criterias were male, weighing 200-250 gr, 
and healthy. Exclusion criterias were less active appearance 
and separating themselves when adaptation to the environ-
ment around the cage. Rat were divided into three groups 
after 2 weeks adapatation. Group 1 was negative control 
group given 100 ug single dose of Peptidoglycan. Group 2 
was treatment group given 100 ug Peptidoglycan intra-ar-
ticularly and single dose Propolis 100 mg/kgBW/day orally. 
Group 3 was a positive control group given 100 ug Peptido-
glycan with Celecoxib 50 mg/kgBW/day orally. 
All groups were sacrificed on day 1, 3 and 14. Knee 
joints of each group were preserved in paraffin block for 
histopathology and immunohistochemistry evaluation. His-
topathology changes of synovitis were evaluated by Hema-
toksillin Eosin staining using Krenn’s scale. Macrophages 
activity was assessed by numbers of macrophages seen 
through immune-expression CD-68 using by immunohisto-
chemistry staining. The scoring were analyzed by ANOVA.
Results
On day-1, histopathology finding using hematoxilin eo-
sin staining shows mild synovitis in 1-2 layers of synovial 
lining with normal cellularity and absence of multinucle-
ate cells. The infiltration of inflammatory cells are found 
at perivascular areas and the mean score range between 2 
to 3 (Figure 1). The mean Krenn’s score for each research 
groups are 2.6 for group 1, 2.2 for group 2 and 3. There is 
no significant difference among the three study groups (p 
<0.05). On day 3, there is an increase of synovitis severity 
degree compared to day 1. The range of  Krenn’s score at 
day 3 are between 3.6 to 5. Histopathology findings are sy-
novitis variation in 4-5 layers of synovial lining, increased 
cellularity, macrophage and aggregation inflammatory cells. 
There is significant difference (p<0.05) between Group 1 
and Group 2-3. (Figure 2) On day 14,  histopathology find-
ing of synovitis is improved. Mean score  range between 
1.2 to 2.2 (Figure 1). There is no difference between Group 
1 and Group 3. Histopathology changes showed 2-3 layers 
of synovial lining with hypo cellularity but in some prepa-
rations are still found without aggregation multinucleated 
macrophages inflammatory cells. There is statistically sig-
nificant differences (p <0.05) between Group 2 (1.2), group 
1 (2.2) and group 3 (2.2).
Among the three days of observation, data on day-3 was 
chosen to evaluate the difference between the three groups 
of studies statistically by using ANOVA in PASW/SPSS 18. 
There were significant differences between Group 2 among 
the two other groups (1 and 3) (p <0.05). When compared 
between the two anti-inflammatory substances, Propolis is 
more superior to Celecoxib to inhibit synovitis process as 
6% (0.6 / 3.6 x 100%).
Immunohistochemistry CD-68 staining in all three 
groups can be seen in Figure 3. The ratio between the 
numbers of macrophage cells that labelled by CD-68 as 
compared with other inflammatory cells was calculated in 
percentages and incorporated into the score. The highest 
number of macrophages that labelled CD-68 is found in 
group 1 observed on day 3. Whereas the lowest number of 
macrophage cells is found in group 2 observed on day 14. 
On day-3, there is difference in number of macrophage cells 
between group 2 with group 1 and 3. Group 2 average score 
is 1.75 with SD 0.500 while the Group 1 is 3 with SD 0.816.
Discussions
Administering a single dose Peptidoglycan 100 mg intra-
articularly in knee joint to all groups, leads to synovitis 
changes as early as 2 hours after injection and clearly visi-
ble through the light microscope on day 1 treatment. The re-
sult is consistent with the previous research.11 It also causes 
activation and proliferation of macrophage from the resi-
dent cell (synoviocytes type A)12, and polymorphonuclear 
(PMN) cell as inflammatory responses.13 
The effect of oral anti-inflammatory substances to the 
number of macrophages in synovitis still can not be identi-
Table 1. Krenn’s score to evaluate histopathological finding in synovitis11
Scale Synovial Lining Resident cell/Macrophage Inflammatory cell
0 1-2 layers Normocellular No infiltration 
1 2-3 layers Mild hypercellular Mild increased at perivascular
2 4-5 layers Moderate hypercellular, multinucleated Moderate increased, aggregation and fol-
licle formation 
3 > 5 layers, ulcer (+),  Multi-
nucleated
Severe hypercellular, with pannus and 
granuloma formation 
Wide aggregation with thickening of 
infiltrate 
0-1= normal, 2-3 = mild synovitis, 4-6 = moderate synovitis and 7-9 = severe synovitis.
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migrating inflammatory cell or activation of resident cell. 
The CD-68 immunohistochemistry staining is able to dif-
ferentiate origin of macrophage whether inflammatory cells 
or resident cell.14
On day 1, the arthrogenic effect of peptidoglycan re-
mains strong to cause damage to the joint.15 It causes PMN 
cells migration from blood vessels to the inflammation site 
as result of cellular inflammation response.16 At that stage, 
the body’s defense efforts made  by PMN cells resulting 
in activation and proliferation of PMN cells.15 The role of 
Propolis at day-1 as anti inflammation effect has not been 
seen clearly, because the optimal level of Propolis has not 
been reached. At this level, the concentration of active com-
pound Propolis should be bigger than optimal dose.17 The 
pharmacokinetics and pharmacodynamics of Propolis has 
not been studied so that the data regarding the bioavailabil-
ity of CAPE and flavonoids in blood is unrevelaed. There 
is no significant difference among three groups. However, 
this result is consistent with the anti-inflammatory effect of 
Propolis against paw edema rats in which these effects occur 
after 48 hours18 whereas the optimal dose of propolis was 
reached.
The scoring of degree synovitis on day 3 shows moderate 
synovitis. The cellular response of PMN cells will increase 
to stimulates activation and proliferation of macrophage 
(resident cell).14,15 It occurs due to increased production of 
cytokines and pro-inflammatory chemical mediators such 
as IL-1β, IL-12, IL-2, IL-4, 8 and Nitric oxide (NO)15  and 
will stimulate the production of TGF-β18 released by in-
flammatory cells and macrophages that migrate from the 
blood vessels16 hence causing a chain reaction of cell dam-
age.14 The effect of Peptidoglycan inducing inflammation is 
reduced or diminshed so that the cellular response that oc-
curs due to aggregation of PMN and macrophages that have 
developed.11, 17 The role of Propolis as anti inflammation is 
clearly visible on day 3. Propolis reduces proliferation of 
synovial macrophages by inhibiting of NO, LTA and COX 
and terminating free radical reaction.15 The inhibitory effect 
of macrophages by Propolis is better compared with Cele-
coxib administration. The difference is assumed that Propo-
Figure 1. Grading severity score of synovitis (Krenn’s Score). 
G1= Peptidoglycan Group, G2= Peptidoglycan and Propolis 
Group, G3 = Peptidoglycan and Celecoxib Group; D1=Day 1, 
D3=Day 3, D14=Day 14
Figure 2. Score of macrophages number in IHC Staining. 
G1= Peptidoglycan Group, G2= Peptidoglycan and Propolis 
Group, G3 = Peptidoglycan and Celecoxib Group;, D1=Day 1, 
D3=Day 3, D14=Day 14.
  
 
Figure 3. Immunohistochemistry staining with CD-68. Macrophage was labelled by antibody monoclonal CD-68 (Brown) and 
inflammatory cell (Blue). A. Group 1 at D-3, B. Group 2 at D-3 and C. Group 3 at D-3. Magnification 100x.
fied clearly because the optimal dose of these substances 
has not been revealed in this study. In HE staining infiltra-
tion of inflammatory cells is found migrating to perivascu-
lar area. However it is difficult to identify and distinguish 
whether the proliferation of macrophages from activation 
lis suppresses both cellular responses7,9 and non-cellular in-
flammation, whereas Celecoxib only suppress non-cellular 
processes through selective inhibition of COX-2.
On day 14, the histopathology findings of all groups 
show improvement of the inflammatory response. It occurs 
due to induction of Peptidoglycan to produce cytokines and 
anti-inflammatory mediators is diminshed.11 It also occurs 
due to healing process of synovitis, in which inflammation 
and infiltration of cells are minimal so that the production 
of cytokines and chemokine in inflammation cascade dim-
inshed.  Propolis action as macrophages immunomodulator9 
in the healing process can be seen from the milder degree 
of synovitis than the other two groups. Although there is in-
hibition of macrophage activation and proliferation, Propo-
lis stimulates the release cytokines and anti-inflammatory 
chemical mediators such as IL-8 and TGF beta. Meanwhile, 
inhibition of COX-2 by Celecoxib,6 leads to decreased level 
of prostaglandin E, results in decreasing number of macro-
phages in group 3. Its ingition effect is lower compared to 
group 1 and  2 but the inhibitory effect is still stronger than 
group 3.
Synovitis has been described that an increase whether 
both inflammatory cells that migrate through the blood ves-
sels or macrophage resident cells are settled. Macrophage 
can stimulate and activate fibroblasts responsible for the 
release of cartilage collagen-degrading enzymes which 
stimulate osteoclasts and bone resorbtion and activate the 
immune system by stimulation of IL-1 and TNF-α.6,14,15 In-
fluence of fibroblast activation does not occur because of di-
minshed effect of Peptidoglycan as inflammation-induced.
Based on the observation histopathologically at day-3, 
it is assumed that Propolis is also able to inhibit prolifera-
tion of inflammatory cells in synovitis, which is proven by 
HE and immunohistochemistry staining of CD-68. Accord-
ing to the literature, the content of CAPE and Flavonoids 
of Propolis has shown to inhibit macrophage inflammatory 
processes in the synovial, it can also inhibit the activity and 
proliferation of inflammatory cells and a layer of the syno-
vial in vitroly.14,17  These results suggest that the inhibitory 
effect of Propolis on cell inflammatory cells and inflamma-
tory processes also occur in vivo situation. But the exact 
mechanism of response inhibition of Propolis to the non-
cellular inflammation response of cytokines and chemical 
mediators both pro-inflammatory and anti-inflammatory 
is not fully understood. Further research to eluccidate the 
role of Propolis against non-cellular responses such as pro-
inflammatory cytokines and anti-inflammatory and pharma-
codynamics in synovitis should be studied.
Conclusions
Propolis has an anti-inflammatory effect stronger than Ce-
lecoxib with variation between 4-5 times higher in reducing 
the number of CD-68 macrophages in rat with knee joint sy-
novitis. Further research should be studied in order to reveal 
anti-inflammatory effect of Propolis against non-cellular re-
sponses and its side effects in long term use.
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